Mesoblast Rare Pediatric Disease Tag for Revascor in Children With Congenital Heart Disease

 REVASCOR Increases Size of Left Heart Chamber and Improves Surgical Outcomes in Children with Hypoplastic Left Heart Syndrome: Results Published in Journal of Thoracic and Cardiovascular Surgery Open

https://www.globenewswire.com/news-release/2024/01/18/2812039/0/en/United-States-Food-Drug-Administration-FDA-Grants-Mesoblast-Rare-Pediatric-Disease-Designation-for-Revascor-Rexlemestrocel-L-in-Children-With-Congenital-Heart-Disease.html